Basel Medical Group Ltd Ordinary Shares (BMGL) vs Pulmatrix, Inc. (PULM)
A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Pulmatrix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.31HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PULM
Pulmatrix, Inc.
$1.48HealthcareDelayed quote: Oct 6, 2026, 12:28 PM EDT
Total return — BMGL vs PULM
growth of $100 · dividends reinvested · last 2yBMGL -94.1% (-75.6%/yr)PULM -81.1% (-56.5%/yr)PULM compounded faster over this window
BMGL PULM
BMGL vs PULM: by the numbers
- •PULM is the larger company ($5M vs $5M market cap).
- •Both run net losses; PULM's is the smaller (0.00% vs -106.78% net margin).
Metrics side by side
Valuation
| Metric | BMGL | PULM |
|---|---|---|
| P/B ratio | 1.06 | 3.40 |
Profitability
| Metric | BMGL | PULM |
|---|---|---|
| Gross margin | 77.68% | 0.00% |
| Operating margin | -19.28% | 0.00% |
| Net margin | -106.78% | 0.00% |
| ROE | -248.66% | -156.94% |
| ROIC | -35.07% | -160.81% |
Growth (annualized)
| Metric | BMGL | PULM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -37.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.